Literature DB >> 19438555

Development of bullous pemphigoid during treatment of psoriasis with adalimumab.

B Stausbøl-Grøn, M Deleuran, E Sommer Hansen, K Kragballe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19438555     DOI： 10.1111/j.1365-2230.2008.03204.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  10 in total

1.  Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report.

Authors:  Wenjuan Chen; Chen Peng; Jianfeng Zheng; Xiya Lu; Yangfeng Ding; Lina Su
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-07

Review 2.  Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.

Authors:  Martina Burlando; Niccolò Capurro; Astrid Herzum; Emanuele Cozzani; Aurora Parodi
Journal:  Dermatol Ther       Date:  2021-11-30       Impact factor: 3.858

3.  Bullous pemphigoid during ustekinumab therapy.

Authors:  Aurore Le Guern; Salim Alkeraye; Annie Vermersch-Langlin; Patrick Coupe; Marlène Vonarx
Journal:  JAAD Case Rep       Date:  2015-10-02

4.  Etanercept-induced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient.

Authors:  Erin N Wilmer; Nils Becker; Allison Chen; George Kroumpouzos
Journal:  JAAD Case Rep       Date:  2016-01-22

5.  Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis.

Authors:  Laurel L Wessman; Elizabeth K Blixt; David A Wetter; Rachel Y Miest
Journal:  JAAD Case Rep       Date:  2017-07-19

6.  Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis.

Authors:  Sebastian Hoffmann; Mark Berneburg; Stephan Schreml
Journal:  Case Rep Dermatol       Date:  2018-05-24

Review 7.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

8.  Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.

Authors:  Noritada Yoshikawa; Erika Matsubara; Motohisa Yamamoto; Hiroki Yamazaki; Masaaki Uehara; Masahiro Kamata; Hirotoshi Tanaka
Journal:  Intern Med       Date:  2020-07-07       Impact factor: 1.271

9.  Superimposed Effects of Adalimumab and Linagliptin on the Development of Bullous Pemphigoid in a Psoriatic Patient: A Case Report.

Authors:  Katsuhiro Yamada; Mai Noto; Takehiro Yamakawa; Motomu Manabe; Shin-Ichi Osada
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

Review 10.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.